Crossmark

Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients

Crossref DOI link: https://doi.org/10.1016/j.ad.2025.104569

Published Print: 2026-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Villarreal-Villarreal, C.D. https://orcid.org/0000-0003-2432-2517
Boland-Rodriguez, E. https://orcid.org/0000-0002-5077-9468
Mares-Custodio, D. https://orcid.org/0000-0002-0432-1149
Asz-Sigall, D. https://orcid.org/0000-0001-6287-0042
Molina-de la Garza, J.F. https://orcid.org/0000-0001-6315-5462
Saceda-Corralo, D. https://orcid.org/0000-0003-2773-7494
Vano-Galvan, S. https://orcid.org/0000-0003-1848-5686
License Information

Text and Data Mining valid from 2026-05-01

Text and Data Mining valid from 2026-05-01

Version of Record valid from 2025-12-16
More Information

This article is maintained by: Elsevier

Article Title: Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2025.104569

Content Type: article

Copyright: © 2025 Published by Elsevier España, S.L.U. on behalf of AEDV.